SaveYourself.ca helps you solve pain problems

COLUMNS
Check the columns you would like to see displayed …
Rating Type Title Keywords
Quote? Author Link Notes
Abstract Vol No. Pages
Month Year Publisher
Please wait, sorting table...

Musculoskeletal Bibliography

titlePlatelet-Rich Plasma Injection for Chronic Achilles Tendinopathy: A Randomized Controlled Trial
typearticle in a journal
pubmedhttp://www.ncbi.nlm.nih.gov/pubmed/20068208
  open in this window or new window
linkhttp://jama.ama-assn.org/cgi/content/abstract/303/2/144
  open in this window or new window
authorsRobert J. de Vos, Adam Weir, Hans T. M. van Schie, Sita M. A. Bierma-Zeinstra, Jan A. N. Verhaar, Harrie Weinans, and Johannes L. Tol
keywordstendinitis
journalJournal of the American Medical Association
year2010
volume303
number2
pages144-149
abstract
CONTEXT: Tendon disorders comprise 30% to 50% of all activity-related injuries; chronic degenerative tendon disorders (tendinopathy) occur frequently and are difficult to treat. Tendon regeneration might be improved by injecting platelet-rich plasma (PRP), an increasingly used treatment for releasing growth factors into the degenerative tendon.
OBJECTIVE: To examine whether a PRP injection would improve outcome in chronic midportion Achilles tendinopathy. Design, Setting, and Patients A stratified, block-randomized, double-blind, placebo-controlled trial at a single center (The Hague Medical Center, Leidschendam, the Netherlands) of 54 randomized patients aged 18 to 70 years with chronic tendinopathy 2 to 7 cm above the Achilles tendon insertion. The trial was conducted between August 28, 2008, and January 29, 2009, with follow-up until July 16, 2009. Intervention Eccentric exercises (usual care) with either a PRP injection (PRP group) or saline injection (placebo group). Randomization was stratified by activity level.
MAIN OUTCOME MEASURES: The validated Victorian Institute of Sports Assessment-Achilles (VISA-A) questionnaire, which evaluated pain score and activity level, was completed at baseline and 6, 12, and 24 weeks. The VISA-A score ranged from 0 to 100, with higher scores corresponding with less pain and increased activity. Treatment group effects were evaluated using general linear models on the basis of intention-to-treat.
RESULTS: After randomization into the PRP group (n = 27) or placebo group (n = 27), there was complete follow-up of all patients. The mean VISA-A score improved significantly after 24 weeks in the PRP group by 21.7 points (95% confidence interval [CI], 13.0-30.5) and in the placebo group by 20.5 points (95% CI, 11.6-29.4). The increase was not significantly different between both groups (adjusted between-group difference from baseline to 24 weeks, -0.9; 95% CI, -12.4 to 10.6). This CI did not include the predefined relevant difference of 12 points in favor of PRP treatment.
CONCLUSION: Among patients with chronic Achilles tendinopathy who were treated with eccentric exercises, a PRP injection compared with a saline injection did not result in greater improvement in pain and activity.
3 related items These 3 items have been specifically marked as related to this item.

“Use of autologous platelet-rich plasma to treat muscle strain injuries,” an article in American Journal of Sports Medicine, 2009.

“Popular Blood Therapy May Not Work,” a webpage on New York Times.

“A Case Study In Aggressive Quackery Marketing,” a webpage on ScienceBasedMedicine.org.

2 articles citing this recordThese 2 articles on SaveYourself.ca cite this item as a source:
SY Save Yourself from Muscle Strain!
SY The Graston Technique®